October 7, 2015 Single Topic Symposium: STOPNASH
October 9—10, 2015 APGNN Annual Meeting
October 9—10, 2015 CPNP Annual Symposium
1

Dear Colleagues:
We invite you to attend “The NASPGHAN Annual Meeting and Postgraduate Course” to be held in Washington, D.C., from Thursday, October 7, 2015—Sunday, October 11, 2015 at the Washington Hilton Hotel.
This year the meeting will be preceded by a Single Topic Symposium on Wednesday directed by Dr. Miriam Vos entitled
“STOPNASH: Symposium on the Origins and Pathways of Nonalcoholic Steatohepatitis.” The planning committee has assembled an outstanding program that will engage the interest of clinicians, academicians, nurses, nutrition and allied health professionals, and trainees alike. An advocacy “Day on the Hill” sponsored by NASPGHAN will take place on Wednesday afternoon.
The meeting will begin on Thursday, with our one-day Postgraduate Course, organized by the Professional Education
Committee (led by Drs. Melanie Greifer and Jennifer Strople). The course will provide a comprehensive overview of pediatric endoscopy, hepatology, nutrition, intestinal inflammation and motility disorders. We will also have small group learning luncheons that will provide more in-depth case based discussion of difficult patients with functional GI disorders, complications of IBD, jaundice, liver failure, and in need of interventional endoscopy. For the first time this year, there will be the opportunity of earning 20 MOC part II credits by participating to the NASPGHAN Postgraduate Course.
The Annual Meeting will begin at 5 PM Thursday evening with a Welcome Reception and the first Poster Session.
On Saturday morning, we are planning to have our second 5K run, following the success of last year.
On Friday and Saturday mornings during the plenary sessions, the best laboratory and clinical science abstracts will be presented. The Keynote speaker this year will be Dr. Atul Grover, the Director for Health Policy at the Association of the
American Medical Colleges, an engaging speaker, who will discuss the impact of health care reform on the practice of pediatric gastroenterology and Dr. Griffin Rogers, Director of the National Institute of Diabetes and Digestive and
Kidney Disease who will discuss how pediatric gastroenterology and hepatology and nutrition fits into his Institute’s research portfolio. Drs. Nicola Jones and Bill Balistreri will present the very popular Basic and Clinical Science Year in
Review sessions.
This year, we have changed the format of the concurrent sessions. Each of the sessions will have clinically relevant presentations as well as research abstracts and a state-of-the art presentation by one of our NASPGHAN thought leaders in the field. There will be 19 concurrent sessions, including two “Hot Topics” sessions that will discuss issues such as management of challenging patients with IBD, EoE, and constipation and when to modify or stop therapy in IBD, EoE or after liver transplantation. There will be parallel sessions focusing on ethics on Friday, enhancing understanding of the
FDA on Friday and Saturday, the Annual APGNN meeting for nurses on Friday and Saturday, a Nutrition Symposium directed toward the interests of dietitians on Saturday and a Clinical Psychology Symposium aimed at the interests of child psychologists on Saturday. The virtual session this year will focus on NAFLD and will be chaired by Drs. Melanie
Greifer and Alan Leichtner. The Hands-on Endoscopy course will again be organized by Dr. Marsha Kay, and Dr. Jose
Cocjin will direct the Hands-on Motility course with applications related to impedance studies. Another session will provide a timely update to clinicians on the topic of practice economics. On Friday evening, the Professional Development
Workshop, open to all attendees and organized by Dr. Benjamin Gold and Camille Bonta, will focus on “advocacy” followed by a session on MOC with Dr. David Nichols from ABP. In keeping with the multicultural spirit of the meeting, we will continue to have a LASPGHAN meeting and reception in Spanish, on Friday evening. On Sunday morning, we will have a Research Skills Workshop with the participation of many of the most accomplished clinical and bench researchers in our specialty.
There will be 16 breakfast sessions (2 in Spanish) which will facilitate more intimate interaction between speakers and society members. Finally, the meeting will end with the tremendously entertaining and instructive GI Jeopardy for Fellows and Faculty and the fun and nutritious social program that will foster the continuing relationships of our members and guests!
Carlo Di Lorenzo MD
President, NASPGHAN
James E. Heubi, MD
President–Elect, NASPGHAN
1

James Heubi MD (NASPGHAN President-Elect) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Program Committee Chair
Jose Cocjin MD (Chair, Neurogastroenterology and Motility Committee) . . . . . . . . . . . . . . . . . . . . . . Hands on Motility, Motility Sessions
Jennifer Crouse MS, RD, CD, CDE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Nutrition Symposium
Carlo Di Lorenzo MD (NASPGHAN President) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Program Advisor
Maureen Egan MSN, APN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . APGNN Program Chair
Udeme Ekong MD (Chair, Hepatology Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Liver Sessions
Doug Fishman MD (Chair, Endoscopy Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Endoscopy Sessions
Benjamin Gold MD (Chair, Professional Development Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . Professional Development Session
Praveen Goday MBBS (Chair, Nutrition Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Nutrition Symposium
Melanie Greifer MD (Chair, Professional Education Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Postgraduate Course, Co-Director
Neera Gupta MD, MAS (Chair, Research Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Annual Meeting
Diane Kocovsky APRN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . APGNN President
Alfredo Larossa-Haro MD (Mexican Councilor) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . LASPGHAN Program
Ian Leibowitz MD (Chair, Clinical Care and Quality Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Clinical Vignette Posters
Michael Narkewicz MD (Chair, Finance Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Meeting Budget
Adam Noel MD (Chair, Clinical Practice Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Clinical Practice Forum
Shehzad Saeed MD (Chair, IBD Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IBD Sessions
Miguel Saps MD (Chair, International Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . LASPGHAN Program
Cary Sauer MD (Chair, Training Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Teaching and Tomorrow Program
Jennifer Strople MD (Vice Chair, Professional Education Committee) . . . . . . . . . . . . . . . . . . . . . . . . . . Postgraduate Course, Co-Director
1919 Connecticut Avenue, NW / Washington, DC 20009
Phone: 1–202-483-3000 / 1–800–Hiltons
. . . . . . . . . . September 17, 2015
. . . . . . . . . . . . . . . . . . . . . . . . . . . . Single/Double: $245.00
Special NASPGHAN room rates. Applicable taxes will be added. (US rate subject to change based on current exchange rates).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4:00 PM
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11:00 AM
To obtain the special NASPGHAN room rates, register online via the NASPGHAN website. Click on “Meetings” from the homepage, then the “Annual Meeting” page where you will see a link to book your room online. Or, call the Hotel’s
Reservation line at 1-800-Hiltons and make sure to identify yourself as attending the NASPGHAN Annual Meeting and Postgraduate Course.
Located in the heart of Washington, DC, the Washington Hilton Hotel is situated near the capital's most sought-after neighborhoods.
Enjoy the best entertainment and nightlife Washington has to offer at the nearby Adams Morgan, Woodley Park and the U Street Corridor.
This Washington, DC hotel is one mile from the Smithsonian National Zoo and only four blocks from the Dupont Circle Metro. Discover iconic
Washington attractions including the White House, National Monument and Lincoln Memorial.
Situated on fashionable upper Connecticut Avenue, the hotel is within walking distance of excellent restaurants, shopping, and entertainment, and near Embassy Row and the Adams Morgan neighborhood. In the Adams Morgan district you can enjoy a variety of unique stores, diverse dining options, entertainment, salons and spas. This vibrant neighborhood is popular with many of Washington’s visitors.
FROM NEAREST METRO STATION (Dupont Circle): The Dupont Circle Metro Station, on the Red Line, is the closest Metro Station to the hotel. Exit at the north end of the Station to Q Street and walk 4 blocks north on Connecticut Avenue to Hilton Washington, located at 1919 Connecticut Avenue.
DETAILED TRANSPORTATION INFORMATION IS AVAILABLE HERE: (http://www3.hilton.com/en/hotels/district-of-columbia/ washington-hilton-DCAWHHH/maps-directions/index.html)
2 # NASPGHAN15

The DEADLINE for the Early–Bird Registration Rates is
August 3, 2015 u To receive Early-Bird rates if mailing payment, envelope must be postmarked no later than August 3, or standard rates will apply.
u After August 3, Standard Rates are applicable. Fees for the
Postgraduate Course and Annual Meeting will increase by $50 per category.
The DEADLINE for the Standard Registration Rates is
September 2, 2015 u To receive Standard rates if mailing payment, envelope must be postmarked no later than September 2, or On-site registration rates will apply.
u After September 2, on site fees are applicable. Fees for the
Postgraduate Course and Annual Meeting will increase by $50 per category.
Register by mail, fax or log in to the member center at (www.
naspghan.org) to register online. Alternately, mail or fax the
registration forms located on Pages 32—41 of this brochure to the
NASPGHAN National Office. Meeting confirmations, tickets and badges will be mailed 3 weeks prior to the meeting.
EDUCATIONAL MISSION STATEMENT: The educational mission of the North American Society for Pediatric
Gastroenterology, Hepatology and Nutrition is to: u Advance understanding of normal development, physiology and pathophysiology of diseases of the gastrointestinal tract, liver and nutrition in children.
u Improve professional competence, quality of care, and patient outcomes by disseminating knowledge through scientific meetings, professional, and public education.
Our activities, education, and interventions will strive to use Adult
Learning Methods (ALM) designed to improve competence, practice performance, and patient outcomes in measureable ways. These educational activities will be targeted to pediatric gastroenterologists, physicians with an expertise in pediatric gastroenterology, hepatology, and nutrition, subspecialty fellows in pediatric gastroenterology, and nurses specializing in pediatric gastroenterology, hepatology, and nutrition.
OBJECTIVES NASPGHAN ANNUAL MEETING 2015:
To improve clinical competence and performance by: u Being acquainted with new discoveries in the pathophysiology of gastrointestinal, pancreatic, hepatobiliary and nutritionrelated diseases.
u Exposure to state-of-the art techniques that can be applied to the diagnosis and treatment of gastrointestinal, hepatobiliary, pancreatic and nutrition-related diseases.
u Becoming more familiar with the changing health care environment, the regulatory process by which new discoveries come to application, and the importance of advocacy and ethics in the practice of pediatric gastroenterology, hepatology and nutrition.
3
NASPGHAN is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for physicians.
NASPGHAN designates this live activity for a maximum of
40.25 AMA PRA Category 1 Credit(s)™ (9.0 credit hours for the
Single Topic Symposium, 8.25 credit hours for the Postgraduate
Course, and 23.0 credit hours for the Annual Meeting). Physicians should only claim credit commensurate with the extent of their participation in the activity.
NASPGHAN is very pleased to provide MOC Part II credit for the 2015 NASPGHAN Postgraduate Course. This activity will provide TWENTY MOC Part II credits for participants who are able to answer at least 70% of the multiple-choice questions correctly. The activity involves 50 multiple-choice questions and can be completed at any time beginning on
October 8, 2015 until November 30, 2015. Credit will be applied in 2015; thus participants whose MOC deadlines are in December 2015 may apply these credits towards their maintenance of certification.
In order to receive this credit you will need the following items ready: u Your ABP ID u Correct and up to date contact information (If there is an error in processing your credits and we cannot reach you, you will
NOT receive the credit)
As always, the NASPGHAN MOC Task Force is here to help you, please contact us with any questions (858) 576-1700 x4778 or
( naspghanmoc@ucsd.edu)
In order to ensure independence, objectivity and scientific rigor in all activities and in accordance with the ACCME, ANCC and
ACPE Standards for Commercial Support, all those in a position to control the content of an educational activity are required to disclose their relevant financial relationships. This includes indicating that one has nothing to disclose. Disclosure information will be distributed to the activity attendees.
In compliance with the Americans with Disabilities Act of 1990,
NASPGHAN will make all reasonable effort to accommodate persons with disabilities. Contact NASPGHAN in order to make arrangements.
NASPGHAN National Office
PO Box 6
Flourtown, PA 19031
Telephone: 215–233–0808
Fax: 215–233–3918
Email: naspghan@naspghan.org
Website: www.naspghan.org
# NASPGHAN15

Wednesday, October 7, 2015
STOPNASH: S
t
O
P
N
a
S
h
COURSE DIRECTORS: MIRIAM VOS MD, ARIEL FELDSTEIN MD, JOEL LAVINE MD, ROHIT KOHLI MD
The overall objective of “STOPNASH: Symposium on The Origins and Pathways of Nonalcoholic Steatohepatitis” is to bring together experts from diverse fields in order to generate synergy in pediatric nonalcoholic fatty liver disease research, to develop consensus regarding priorities in pediatric NAFLD research and to encourage young investigators and investigators from diverse backgrounds to study NAFLD in order to improve prevention and treatment of NAFLD. Specific aims include: u u u u
Bring together basic, translational, clinical and population NAFLD researchers from the fields of endocrinology, lipidology, metabolism, nutrition, and hepatology to share their work and develop synergy and collaboration.
Define, prioritize and widely communicate a future research agenda for pediatric NAFLD.
Provide support, networking and potential collaboration to young investigators.
Inform the wider community of researchers of the findings from this conference.
8:00 AM—8:05 AM INTRODUCTION: THEMES AND GOALS OF CONFERENCE
Miriam Vos, MD
8:05 AM—8:25 AM
8:25 AM—8:45 AM
8:45 AM—9:05 AM
9:05 AM—9:25 AM
9:25 AM—9:45 AM
9:45 AM—10:00 AM
PATTERNS OF NAFLD AROUND THE WORLD
Jeff Schwimmer MD, University of California, San Diego
PUTTING NAFLD IN PERSPECTIVE: AN OVERVIEW OF THE PATHOPHYSIOLOGY
Brent A. Neuschwander-Tetri MD, St. Louis University
GENETICS PLUS THE ENVIRONMENT: THE SUGAR EFFECT ON PNPLA3
Michael Goran MD, Keck School of Medicine, University of Southern California
NAFLD AND TYPE II DIABETES
Sonia Caprio MD, Yale University School of Medicine
PANEL DISCUSSION
BREAK
10:00 AM—10:20 AM MATERNAL INSULIN RESISTANCE AND NAFLD DEVELOPMENT
Jed Friedman MD, University of Colorado School of Medicine
10:20 AM—10:40 AM FATTY ACID DYSREGULATION IN NAFLD
Elizabeth Parks MD, University of Missouri School of Medicine
10:40 AM—11:00 AM
11:00 AM—11:20 AM
FRUCTOSE AND THE LIVER: MORE THAN JUST EXTRA CALORIES?
Rob Lustig MD, University of California, San Francisco
MICROBIOME AND NAFLD IN CHILDREN
Marialena Mouzaki MD, The Hospital for Sick Children
11:20 AM—11:40 AM
11:40 AM—12:00 PM
12:00 PM—1:00 PM
GENETICS AND NAFLD: WHAT WE KNOW SO FAR
Nicola Santoro MD, Yale University School of Medicine
PANEL DISCUSSION
LUNCH IN SMALL GROUPS – BREAKOUT SESSIONS TO DEFINE RESEARCH PRIORITIES
Moderators to lead small groups
1:10 PM—1:30 PM CROSSTALK BETWEEN ADIPOCYTES AND HEPATOCYTES
Nitika Gupta MD, Emory University
4
SINGLE TOPIC SYMPOSIUM CONTINUES . . .

1:30 PM—1:50 PM
1:50 PM—2:10 PM
2:10 PM—2:30 PM
2:30 PM—2:50 PM
2:50 PM—3:10 PM
OXIDIZED LIPIDS AND LINOLEIC ACID IN NASH
Christopher Ramsdam MD, National Institutes of Health
STERILE INFLAMMATION AND CELL DEATH
Ariel Feldstein MD, University of California, San Diego
NASH: WHAT’S BILE GOT TO DO WITH IT?
Rohit Kohli MD, Cincinnati Children’s Hospital Medical Center
PANEL DISCUSSION
BREAK
3:10 PM—3:30 PM
3:30 PM—3:50 PM
3:50 PM—4:10 PM
4:10 PM—4:30 PM
WHAT DOSE OF EXERCISE REDUCES INSULIN RESISTANCE IN CHILDREN AND
APPLICATION TO NAFLD
Catherine Davis MD, Georgia Regents University
INTERVENTIONS AND POLICIES TO PREVENT OBESITY AMONG VULNERABLE CHILDREN
Jennifer Woo Baidal MD, Boston Children’s Hospital
PREVENTION AND TREATMENT OF CHILDHOOD OBESITY: WHAT CAN WE LEARN AND
APPLY TO PREVENTION OF NAFLD?
Sarah Barlow MD, Baylor College of Medicine
PANEL DISCUSSION
4:30 PM—4:45 PM
4:45 PM—5:00 PM
5:00 PM—5:15 PM
5:15 PM—6:00 PM
GOALS OF THE NASH CRN AND OPPORTUNITIES FOR COLLABORATION
Joel Lavine MD, Columbia University
NIDDK PRIORITIES AND PERSPECTIVES
Ed Doo MD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
OPPORTUNITIES FOR COLLABORATION
Veronica Miller PhD, Director, Forum for Collaborative HIV Research and The Liver Forum
PRESENTATION & DISCUSSION OF SMALL GROUP RESULTS
Moderators: Drs. Vos, Kohli, Lavine and Feldstein
Wednesday, October 7, 2015
Policy change happens from the ground up by constituents telling their stories directly to members of Congress. While in
Washington, DC. join fellow NASPGHAN members on Capitol Hill October 7 for an exciting half-day program of advocacy education and lobbying.
The Advocacy Program, which will take place the day before the NASPGHAN Postgraduate Course, will kick-off at noon with lunch on Capitol Hill and a guest speaker. After lunch, participants will attend pre-arranged meetings with congressional lawmakers and staff to advocate for issues important to the pediatric gastroenterology community, including federal legislation requiring health insurance coverage of medical foods for the treatment of pediatric gastrointestinal disorders and increased funding for medical research. NASPGHAN needs the advocacy of its members to help advance this important cause.
The registration fee will cover lunch, briefing materials, custom congressional meeting schedules, and information packets for lawmakers. Reimbursement for transportation costs to and from Capitol Hill will also be available.
Don’t miss out on this important opportunity to advocate for your patients and to introduce you and your profession to legislators.
Once registered for the Advocacy Program, you will receive further instruction and information to help prepare for your
Capitol Hill visits.
5
#
is the official hashtag of the 2015 NASPGHAN Annual Meeting and Post
Graduate Course. Please include it when posting about the event acrossyour social media channels.

Thursday, October 8, 2015
COURSE DIRECTORS: MELANIE GREIFER MD AND JENNIFER STROPLE MD
J OBESITY AND THE MICROBIOME
Marialena Mouzaki MD, The Hospital for Sick Children
Learning objectives: u u u
Understand the microbiota in obesity
Learn how dietary composition and caloric intake regulate the microbiota
Know the effect of the microbiota on the complications of obesity such as metabolic syndrome
J REDEFINING MALNUTRITION IN THE 21ST CENTURY
Praveen Goday, MBBS, Children’s Hospital of Wisconsin
Learning objectives: u u u
Discuss the new definitions for malnutrition
Identify patient populations with malnutrition that are likely to be seen by the pediatric gastroenterologist
Discuss the management of different sub-populations with malnutrition
J MANAGEMENT OF FOOD ALLERGIES AND FPIES
Hugh Sampson MD, Icahn School of Medicine at Mount Sinai
Learning objectives: u u u
Discuss factors that may account for the rise in food allergies
Recognize various forms of food allergies including FPIES and other gastrointestinal food allergic disorders
Diagnose and manage various forms of food allergies
6
POSTGRADUATE COURSE CONTINUES . . .

J UPDATES ON CAUSTIC INGESTIONS
Mark McOmber MD, Phoenix Children’s Hospital
Learning objectives: u u u
Know the timing and preparation of intervention
Learn the immediate post procedure management including reintroduction of feeds, NG tubes, etc.
Understand the follow up and long term issues of ingestion including treatment of these issues
J UPDATES ON FOREIGN BODY INGESTIONS
Robert Kramer MD, Children’s Hospital Colorado
Learning objectives: u u u
Know the timing and preparation of interventions dependent on ingestion
Review management of glass and sharps
Know the most current updates on magnets/batteries and detergent pod ingestions
J THE PROBLEMATIC POLYP
Petar Mamula MD, Children’s Hospital of Philadelphia
Learning objectives: u u u
Review prerequisites for successful polypectomy
Discuss techniques for difficult polyps
Review polypectomy complications
J CLOSTRIDIUM DIFFICILE: DIFFICULT BUT NOT IMPOSSIBLE
Stacy Kahn MD, University of Chicago Comer Children’s Hospital
Learning objectives: u u u
Learn appropriate identification and testing for C. Difficile
Know the updates on medical management
Understand fecal transplantation and the ethics involved in its use
J
GLUTEN SENSITIVITY: SURELY A SENSITIVE, BUT PERHAPS NOT A GLUTEN, SUBJECT
Stefano Guandalini MD, University of Chicago Comer Children’s Hospital u u
Learning objectives: u
Define non-celiac gluten sensitivity
Understand the current uncertainties around gluten sensitivity
Know how to approach patients with suspected non-celiac gluten sensitivity
J MEDICAL MANAGEMENT OF REFRACTORY ABDOMINAL PAIN
Adrian Miranda MD, Children’s Hospital of Wisconsin u u
Learning objectives: u Understand the mechanisms of refractory abdominal pain
Identifying the patient with refractory abdominal pain
Know the available and current treatment options
J NAUSEA:  UPDATES THAT WON’T MAKE YOU SICK
Carlo Di Lorenzo MD, Nationwide Children’s Hospital
Learning objectives: u u u
Understand the differential diagnosis of children presenting with nausea as the predominant symptom
Become familiar with the medical interventions with the potential of improving functional nausea
Become familiar with the non-medical interventions with the potential of improving functional nausea
7 # NASPGHAN15

1
BLURRED LINES: WHERE GASTROENTEROLOGY AND ALLERGY INTERSECT
MODERATOR: CHRIS LIACOURAS
Hugh Sampson and Tiffani Hays
2 THE CHILD SWALLOWED WHAT?
MANAGEMENT OF CAUSTIC AND FOREIGN BODY INGESTIONS
MODERATOR: DEEPALI TEWARI
Robert Kramer and Mark McOmber
3 C. DIFFICILE MEETS ITS MATCH: APPROACH TO THE COMPLICATED PATIENT
MODERATOR: SUNPREET KAUR
Stacy Kahn and George Russell
4 GLUTEN SENSITIVITY, MORE THAN A FAD: A CASE BASED DISCUSSION
MODERATOR: KELLY THOMSEN
Stefano Guandalini, Hilary Jericho and Pamela A. Cureton
5 PRACTICAL APPROACH TO TREATING THE PATIENT WITH PERSISTENT PAIN AND NAUSEA
MODERATOR: JOHN STUTTS
Adrian Miranda and Katja Kovacic
6 CHALLENGING LIVER DISEASE CASES
MODERATOR: RITU WALIA
Jean Molleston and Simon Horslen
7 VIRAL HEPATITIS: WHEN DO YOU TREAT?
MODERATOR: VICKY NG
Daniel Leung and Jessica Wen
8 PERPLEXING CASES IN PANCREATITIS
MODERATOR: DEBORAH NEIGUT
Veronique Morinville and Soma Kumar
9 MANAGEMENT OF POUCH AND PERIANAL COMPLICATIONS
MODERATOR: DINESH PASHANKAR
Maria Oliva-Hemker and Joel Rosh
J NEW HORIZONS IN HEPATITIS C
Daniel Leung MD, Texas Children’s Hospital
Learning objectives: u u u
Understand the epidemiology, burden of disease, and natural history of HCV
Appreciate the rapidity and timeline of HCV drug development
Become familiar with clinical indications to treat and soon to be available all-oral treatment regimens
J
RENAL COMPLICATIONS OF CHRONIC LIVER DISEASE
Jean Molleston MD, Riley Children’s Hospital
Learning objectives: u u u u
Define prevalence of renal complications in chronic liver disease
Review mechanisms of ascites and the role of the kidneys and diuretic use
Understand the role of electrolyte monitoring and fluid balance in cirrhosis
Review definition of hepatorenal syndrome and treatment recommendations, including use of terlipressin
8
MODULE 4: LIVER/PANCREAS CONTINUES . . .

J AN UPDATE ON WILSON’S DISEASE
Simon Horslen MD, Seattle Children’s Hospital
Learning objectives: u Review the clinical presentations in pediatric population and typical diagnostic evaluation u u
Understand genetics and patterns of inheritance to focus who should be screened
Understand treatment strategies and side effects of current and future therapies
J BLAME THE GENES? FAMILIAL AND AUTOIMMUNE PANCREATITIS IN CHILDREN
Veronique Morinville MD, Montreal Children's Hospital
Learning objectives: u u u
Understand when to consider familial and autoimmune etiologies in a child presenting with pancreatitis
Review the different genetic factors that may be involved in familial-type pancreatitis
Recognize factors implicated in autoimmune pancreatitis types 1 and 2 and what therapies may be attempted
J GETTING TO THE BOTTOM OF PERIANAL CROHN’S DISEASE
Maria Oliva-Hemker MD, Johns Hopkins University Medical Center
Learning objectives: u u u
Review the classification systems for fistulizing disease
Understand the approach to initial diagnosis and assessment
Review surgical and medical therapy and role for each
J “IT’S ALL ABOUT THAT POUCH, 'BOUT THAT POUCH, NO COLON”:
EVALUATION & MANAGEMENT OF COMPLICATIONS POST ILEAL POUCH ANAL ANASTOMOSIS
Joel Rosh MD, Goryeb Children’s Hospital
Learning objectives: u Review the data for evaluation, treatment and prevention of pouchitis u u
Understand other complications of IPAA
Review cancer screening /surveillance recommendations
J COMMUNICATING THE BENEFITS AND RISKS OF IBD THERAPY TO PATIENTS AND FAMILIES
Corey Siegel MD, Dartmouth-Hitchcock Medical Center
Learning objectives: u u u
Review the risks of immunomodulators and biologics
Discuss decision making between anti-TNF monotherapy or combination therapy
Learn about tools that can be used to better communicate the benefits and risks  of IBD therapy
9 # NASPGHAN15

Thursday, October 8, 2015
5:00 PM —7:00 PM
Friday, October 9, 2015
7:00 AM —8:00 AM
(REGISTRATION REQUIRED)
8:15 AM —10:00 AM
1
FULMINANT COLITIS: DO WE NEED TO CHANGE OUR CURRENT PARADIGM?
Jeffrey Hyams MD and Brendan Boyle MD
2
FUNCTIONAL ABDOMINAL PAIN: IMPLEMENTING NONPHARMACOLOGIC THERAPIES INTO
YOUR PRACTICE
Bruno Chumpitazi MD and Miranda Van Tilburg PhD
3 RECALCITRANT GER
Benjamin Gold MD and Hayat Mousa MD
4
EoE AND ELIMINATION DIETS
Amir Kagalwalla MD and Sally Schwartz RD
5
PUTTING ASSESSMENT OF ENDOSCOPIC COMPETENCE INTO PRACTICE
Catharine Walsh MD and Jenifer Lightdale MD
6
FORMULA MANAGEMENT AND ENTERAL FEEDING
Valeria Cohran MD and Monique L Goldschmidt MD
7 ACUTE PANCREATITIS: BASIC MANAGEMENT AND BEYOND
Aliye Uc MD and Bradley Barth MD
8 DOLOR ABDOMINAL FUNCTIONAL: TODOS LOS ESTUDIOS SON NORMALES,
PERO EL DOLOR SEVERO CONTINÚA. AHORA QUE HAGO? (NO CHARGE)
Samuel Nurko MD and Jose Garza MD
MODERATORS: CARLO DI LORENZO MD AND JAMES HEUBI MD
J BASIC SCIENCE YEAR IN REVIEW
Nicola Jones MD, PhD—The Hospital for Sick Children
J BUSINESS MEETING
J CLINICAL SCIENCE YEAR IN REVIEW
William Balistreri MD, Cincinnati Children’s Hospital Medical Center
10:00 AM—10:30 AM
10:30 AM —12:00 PM
1
MODERATORS: JENNIFER STROPLE MD AND KARA GROSS MARGOLIS MD
J THE EoE HUNGER GAMES: PPI-REE IS CATCHING FIRE!
Edaire Cheng MD, UT Southwestern Medical Center
Learning objectives: u u u
Recognize the similarities, differences, and relationship between GERD, EoE, and PPI-REE
Understand the mechanism of PPI response in PPI-REE patients
Evaluate and treat a patient with esophageal eosinophilia
10
CONCURRENT SESSION I CONTINUES . . .

2
J USE OF CONCOMITANT IMMUNOMODULATORS AND ANTI-TNFS: EMERGING INSIGHTS
Laurie Conklin MD, Children’s National Medical Center
Learning objectives: u u u u
Discuss the evidence for use of concomitant immunomodulators and anti-TNFs
Discuss the effect of concomitant immunomodulators on immunogenicity
Discuss the effect of concomitant immunomodulators on anti-TNF levels
Examine data regarding outcomes when stopping one class of drug
J INTRACTABLE CONSTIPATION: WHAT IS NEXT WHEN YOU ARE STUCK?
Jose Garza MD, Children’s Center for Digestive Healthcare, Atlanta
Learning objectives: u u u
Understand colorectal physiology and defecation dynamics
Distinguish causes of treatment failure in chronic constipation
Enumerate indications of colorectal manometric studies
MODERATORS: RUSSELL MERRITT MD AND ALA SHAIKHKHALIL MD
J LONG TERM COMPLICATIONS OF TPN: NOW THAT MY INTESTINAL FAILURE PATIENTS ARE
NOT DYING OF LIVER DISEASE, WHAT ELSE SHOULD I WORRY ABOUT?
Jane Balint MD, Nationwide Children’s Hospital
Learning objectives: u u u
Identify potential complications of lipid minimization strategies
Describe an approach to micronutrient monitoring in long term parenteral nutrition
Discuss renal and bone complications of parenteral nutrition
J ORAL ABSTRACT PRESENTATION
J COMBATING CLABSIS—
PREVENTING CENTRAL LINE INFECTIONS AND OTHER CENTRAL LINE CHALLENGES
John Kerner MD, Lucile Packard Children’s Hospital
Learning objectives: u u u
Identify evidence based practices for CLABSI prevention
Describe at least one modality for the prevention of catheter-related venous thrombosis
Discuss the approach to the patient with central line occlusion
J ORAL ABSTRACT PRESENTATION
3
MODERATORS: ELIZABETH UTTERSON MD AND STEVEN ERDMAN MD
J
WHEN THE GOING GETS TOUGH: IMPROVING OUTCOMES OF COLONOSCOPY
Jenifer Lightdale MD, UMass Memorial Children’s Hospital
Learning objectives: u u u u
Identify core skills required to perform pediatric colonoscopy safely, effectively and comfortably
Review basic and advanced measures which may help in the performance of difficult colonoscopy
Discuss evidence-based estimates of procedural volume required to achieve competence in colonoscopy
Recognize the value of implementing routine continuous assessment of colonoscopy quality to improving procedural outcomes in an endoscopy unit
J ORAL ABSTRACT PRESENTATION
J POLYPECTOMY: WHO, WHEN, WHY AND HOW
Seth Septer MD, Children’s Mercy Hospital
Learning objectives: u u u
Define the most common causes of polyposis in pediatrics and the risks associated with these polyps
Understand the indications for polypectomy and the recommendations for endoscopic surveillance in patients with polyposis
Review the techniques and equipment used for polypectomy and the potential complications that may occur
J ORAL ABSTRACT PRESENTATION
11
CONCURRENT SESSION I CONTINUES . . .

12:00 PM —2:30 PM
4
5
MODERATORS: MICHELLE PIETZAK MD AND MARIA MASCARENHAS MBBS
J ADVANCES IN CF THERAPIES AND THEIR EFFECT ON GASTROINTESTINAL MANIFESTATIONS
Daniel Gelfond MD, WNY Pediatric Gastroenterology
Learning objectives: u u u u
Outline pathophysiology of CF and impact of CFTR on clinical manifestations
Recognize gastrointestinal manifestations of the cystic fibrosis and discuss therapeutic interventions
Outline recent development and advances in CF therapy targeting specific genetic mutations
Discuss role of wireless motility capsule as gastrointestinal biomarker of CFTR activity
J ORAL ABSTRACT PRESENTATION
J DISCORDANT SEROLOGIES AND BIOPSIES: WHAT TO DO?
Dascha C. Weir MD, Boston Children's Hospital
Learning objectives: u u
Recognize the potential complexities in the use of celiac serologic markers and small intestinal biopsies in clinical practice
Discuss a clinical approach to the treatment and monitoring of patients with discordant serology and biopsies
J
ORAL ABSTRACT PRESENTATION
MODERATORS: ANDREW MULBERG MD AND ATHOS BOUSVAROS MD
J DEMYSTIFYING THE IND
Kerry Jo Lee MD, Food and Drug Administration
Kevin Bugin MS, Food and Drug Administration
Learning objectives: u u
Understanding the role of the IND in clinical research
Learning to navigate the IND process
J
THE INVESTIGATOR AS SPONSOR
James Heubi MD, Cincinnati Children’s Hospital and Medical Center
Learning objectives: u u
Describe responsibilities of an investigator and study sponsor
Describe personal experience as an investigator as a sponsor
12:00 PM —2:00 PM
2:30 PM —4:00 PM
1
2
MODERATORS: STEPHANIE ABRAMS, AMAL AQUL, SARAH BARLOW, MOLLY BOZIC, NIRAV
DESAI, RIMA FAWAZ, ARIEL FELDSTEIN, REGY GONZALES-PERALTA, NITIKA GUPTA, SIMON
HORSLEN, EVELYN HSU, ROHIT KOHLI, JEAN MOLLESTON, NADIA OVCHINSKY, EMILY PERITO,
JEFF SCHWIMMER, DELLYS SOLER-RODRIGUEZ, AND SHIKHA SUNDARAM
Miriam Vos MD, MSPH, FAHA, Emory School of Medicine
Learning objectives: u u u
To address when to biopsy and when to re-biopsy in pediatric NAFLD
To understand dyslipidemia in the setting of NAFLD– how to assess and when to start medications
To discuss treatment with Vitamin E (and other medications)
MODERATORS: RUBA ABDELHADI MD AND TIMOTHY SENTONGO MD
J BACTERIAL OVERGROWTH IN PEDIATRIC SHORT BOWEL SYNDROME
Conrad Cole MD, Cincinnati Children’s Hospital Medical Center
12
CONCURRENT SESSION II CONTINUES . . .

3
4
Learning objectives: u u u u
Learn risk factors for developing bacterial overgrowth
Discuss diagnostic challenges
Understand the differential diagnosis
Review therapeutic options
J ORAL ABSTRACT PRESENTATION
J
STATE OF THE ART RESEARCH LECTURE—CUTTING EDGE OR CRAZY:
IS SURGERY THE MOST EFFECTIVE TREATMENT FOR NASH?
Stavra Xanthakos MD, Cincinnati Children’s Hospital Medical Center
Learning objectives: u u u
Review the current guidelines for when to consider bariatric surgery in youth
Describe the types of bariatric surgeries performed in adolescents, including risks and benefits
Review the evidence and gaps in knowledge re: bariatric surgery as a specific treatment for NASH
J ORAL ABSTRACT PRESENTATION
MODERATORS: ASHISH PATEL, MD AND JEANNE TUNG, MD
J POST-OPERATIVE MANAGEMENT IN PEDIATRIC CROHN’S DISEASE:
HOW SHOULD THE PEDIATRIC GASTROENTEROLOGIST APPROACH THIS IN 2015?
Sandy Kim MD, Nationwide Children’s Hospital u u u
Learning objectives: u Delineate the natural history of post-operative recurrence in patients with Crohn’s disease
Describe different methods for defining, and monitoring for, post-operative recurrence
Review the data on efficacy of different treatment regimens
Discuss therapeutic approaches for effective management post-operatively
J ORAL ABSTRACT PRESENTATION
J HEALTH MAINTENANCE OF IBD (VACCINATION/SKIN)
Paul Rufo MD, Children’s Hospital Boston
Learning objectives: u u
Recognize disease and medication specific concerns related to IBD
Understand risk of cancer in health maintenance screening in children and adolescent with IBD
J
ORAL ABSTRACT PRESENTATION
MODERATORS: HAYAT MOUSA MD AND KATJA KOVACIC MD
J SWALLOWING PROBLEMS IN INFANTS AND TODDLERS: TESTING AND TREATMENT
Richard Noel MD, Duke University Medical Center u u
Learning objectives: u u
Recognize swallowing problems in normal and medically-complex infants and toddlers
Apply nutritional and medical strategies that support growth and diagnose underlying disease
Comprehend the role non-physician colleagues provide to the diagnosis and treatment of swallowing problems
Be empowered to synthesize an executable nutritional plan for infants and children with swallowing problems
J ORAL ABSTRACT PRESENTATION
J
APPROACH TO THE PATIENT WITH DYSPHAGIA: WHEN IT'S NOT EoE . . .
Manu Sood MD, Children’s Hospital of Wisconsin
Learning objectives: u u u
Understand the role of imaging and manometry studies in evaluating children with dysphagia
Understand the pros and cons of using Chicago classification in pediatric patients
Learn about therapeutic options available for management of achalasia and post fundoplication dysphagia
J ORAL ABSTRACT PRESENTATION
13
CONCURRENT SESSION II CONTINUES . . .

4:15 PM —5:15 PM
5:00 PM—6:30 PM
5 u u u u u
MODERATORS: BRUNO CHUMPITAZI MD AND PAUL HYMAN MD
J SHOCKING THE GASTROINTESTINAL TRACT:
ELECTRICAL STIMULATION FROM TOP TO BOTTOM
Steve Teich MD, Nationwide Children’s Hospital
Learning objectives:
Describe the history of GI Tract stimulation
Describe the indications and results of gastric stimulation in pediatric and adolescent patients
Describe the indications and results of sacral nerve stimulation in pediatric and adolescent patients
Describe esophageal stimulation for gastroesophageal reflux disease; A promising new therapy
Describe the barriers to pacing the small intestine. Will it ever become a reality?
J ORAL ABSTRACT PRESENTATION
J STATE OF THE ART LECTURE—BUGGING THE GASTROINTESTINAL TRACT:
MICROBIOME AND THE ENTERIC NERVOUS SYSTEM
Elyanne Ratcliffe MD, McMaster University
Learning objectives: u u u u
Provide an overview of microbial colonization of the GI tract and development of the enteric nervous system
Discuss examples of microbiota-enteric nervous system interactions
Highlight potential clinical implications in the context of early life influences on microbial colonization
Discuss areas of potential research focus from both basic and clinical perspectives
J ORAL ABSTRACT PRESENTATION
Join other psychologists with GI interests to meet and to foster collaboration. In addition, planning discussions for the 2016 World Congress of Pediatric Gastroenterology, Hepatology and Nutrition will take place.
5:30 PM
MODERATORS: BENJAMIN GOLD MD AND TOBA WEINSTEIN MD
J HARNESSING THE POWER OF INDIVIDUAL AND ORGANIZED ADVOCACY
Tom Sheridan — Mr. Sheridan is the founder of The Sheridan Group, a Washington lobbying firm that operates under the belief that the world will be a more livable place when the interests of the common good get the representation they deserve in the halls of government. Mr. Sheridan has designed and led impressive issue campaigns, including
Bono’s ONE Campaign to create PEPFAR. Early in his career, Mr. Sheridan was a member of the AIDS Action Council, where he was the chief architect and strategist behind the enactment of the Ryan White CARE Act.
J THE EFFECTIVE ADVOCATE: A VIEW FROM CAPITOL HILL
Ron Grimes — Mr. Grimes currently serves as Chief of Staff to Congressman Tim Ryan (OH-17). Mr. Grimes previously served as Legislative Affairs for the Federal Emergency Management Agency under President Bill Clinton, and Legislative
Director to Congressman Tom Lantos (CA-12).
J WHAT DOES IT MEAN TO BE A PATIENT ADVOCATE?
George Ferry — Dr. Ferry is a graduate of Stanford. He completed medical school and pediatric residency at Baylor
College of Medicine and a GI Fellowship in the Department of Medicine, Johns Hopkins University School of Medicine.
He was at Baylor College of Medicine from 1970 to 2013, when he retired as Distinguished Emeritus Professor of
Pediatrics. At Texas Children's Hospital, he served as Clinic Chief, started the liver transplant service, and was Chief of the IBD Center when he retired. He has also served on the NASPGHAN Council, helped start the NASPGHAN
Foundation, and has cared for underprivileged children in Bolivia for twenty years.
14
#
is the official hashtag of the 2015 NASPGHAN Annual Meeting and Post
Graduate Course. Please include it when posting about the event acrossyour social media channels.

5:30 PM
7:30 PM
Pediatrics. At Texas Children s Hospital, he served as Clinic Chief, started the liver transplant service, and was Chief of the IBD Center when he retired. He has also served on the NASPGHAN Council, helped start the NASPGHAN
Foundation, and has cared for underprivileged children in Bolivia for twenty years.
J BLACK BOXES AND OTHER WARNINGS
Harland Winter MD, Massachusetts General Hospital for Children
J PEDS GI AND THE FDA
Andrew Mulberg MD, FDA
J
DRUGS IN THE MEDIA
John Pohl MD, Primary Children's Hospital
David Nichols MD, MBA
Friday, October 9, 2015
J 6:00 PM—6:20 PM
J 6:20 PM—6:30 PM
J 6:30 PM—6:55 PM
J 6:55 PM—7:20 PM
J 7:20 PM—7:30 PM
J 7:30 PM—8:05 PM
J 8:05 PM—8 :1 5 PM
J 8 :1 5 PM—8:25 PM
J 8:25 PM—8:30 PM
J 8:30 PM—9:30 PM
WELCOME BY NASPGHAN’S INTERNATIONAL COMMITTEE
WELCOME MESSAGE
Miguel Saps MD, NASPGHAN’s International Committee Chair
INVITATION AND INFORMATION ON LASPGHAN ANNUAL MEETING
Eduardo Hebel MD, LASPGHAN’s President
ABSTRACT AWARD PRESENTATION
NON-CELIAC GLUTEN SENSITIVITY AND FODMAP DIET: MYTH OR REALITY?
Bruno Chumpitazi MD, Texas Children’s Hospital
ENDOSCOPIC MANAGEMENT OF GASTROINTESTINAL BLEEDING AND
FOREIGN BODIES IN CHILDREN
Antonio J Quiros MD, Medical University of South Carolina
ABSTRACT AWARD PRESENTATION
DEBATE: EOSINOPHILIC ESOPHAGITIS
MODERATOR: EDUARDO HEBEL MD
Richard Noel MD, Duke University School of Medicine
Sam Nurko MD, MPH, Boston Children’s Hospital
NEW ADVANCES:
DIAGNOSTIC AND THERAPEUTIC PERSPECTIVES IN EOSINOPHILIC ESOPHAGITIS
Eitan Rubinstein MD, Boston Children’s Hospital
ABSTRACT AWARD PRESENTATION
VOTING RESULTS FOR THE DEBATE
Norberto Rodriguez-Baez MD, UT Southwestern Medical Center
RECEPTION
15 # NASPGHAN15

Saturday, October 10, 2015
6:00 AM —7:30 AM
ND
7:00 AM —8:00 AM
8:15 AM —10:00 AM
10:00 AM—10:30 AM
9
THANKS BUT NO THANKS: DEALING WITH REFUSAL OF MEDICALLY NECESSARY TREATMENT
Sylviane Forget MD and William Wenner MD
10
CROHN’S DISEASE: COMPLICATED CASES
Athos Bousvaros MD and Brian P. Regan Sr. DO
11
MEET THE FDA (NO CHARGE)
Andrew Mulberg MD, Juli Tomaino MD, Jessica Lee MD and Kerry Jo Lee MD
12
TRANSITION TO TRANSFER OF CARE
Laurie Fishman MD and Nitika Gupta MD
13
HEPATITIS B
Phil Rosenthal MD and Douglas Mogul MD
14
MANAGEMENT OF GASTROINTESTINAL AND NUTRITIONAL MANIFESTATIONS OF
CYSTIC FIBROSIS
Maria Mascarenhas MBBS and Meghana Sathe MD
15
CECOSTOMIES AND THEIR MANAGEMENT: HOW TO ACE THE ACE
Leonel Rodriguez MD, Jason Dranove MD and Sheila Bell RN, CPNP
16
LA B DE HEPATITIS EN NIÑOS (NO CHARGE)
Regino Gonzalez Peralta MD and Aymin Delgado-Borrego MD, MPH
MODERATORS: JOHN BARNARD MD AND NEERA GUPTA MD, MAS
J KEYNOTE ADDRESS: 21 ST CENTURY HEALTH CARE POLITICS AND THE CHALLENGES THEY
POSE TO PEDIATRIC ACADEMIC MEDICINE
Atul Grover MD, Association of American Medical Colleges
Learning objectives: u Give the audience an overview of health care politics in Washington, DC:
Federal Budget, Medicare and Medicaid, and NIH u u
Give the audience an understanding of the nation’s changing physician work force and its implications for health care policy and access to care
Discuss for the audience the unique challenges and opportunities the political environment poses for academic medicine in general and pediatric academic medicine in particular
J ORAL ABSTRACT PRESENTATIONS
J KEYNOTE ADDRESS: PERSPECTIVES FROM NIDDK RELATED TO NASPGHAN
Griffin P. Rodgers MD, MACP, Director, National Institute of Diabetes & Digestive and Kidney Disease
10:30 AM—12:00 PM
1
MODERATORS: MICHAEL BATES MD, PHD AND SUDIPTA MISRA MD
J UPDATE ON CPT CODES AND ALTERNATIVE PAYMENT MECHANISMS
Joel Brill, MD, FAIR Health, Inc.
Learning objectives: u u
Understand new CPT codes and their impact on clinical practice
Understand alternative payment mechanisms and their impact on clinical practice
16
CONCURRENT SESSION III CONTINUES . . .

2
J PRACTICE ECONOMICS:  MISSION, MONEY, MIDAS AND MAGIC
David A. Piccoli MD, Children’s Hospital of Philadelphia
Learning objectives: u u u
To review the sources of revenue in an academic practice
To review the expenses and expenditures in an academic practice
To review changes in the structure of pediatric gastroenterology and reimbursement that will affect practice economics and the academic mission in the future.
J NASPGHAN WORKFORCE SURVEY RESULTS: HOW DO WE ALL STACK UP?
Linda Muir MD, FAAP, Oregon Health Science University
Learning objectives: u u u u
Describe demographics of respondents to the 2014-2015 NASPGHAN Workforce Survey
Access the NASPGHAN web-link to view survey data
Describe the limitations for analysis of Work Relative Value Units (WRVUs) and compensation information due to categorical (grouped) answers
List one design suggestion to improve applicability of future workforce surveys
ORGANIZER: JOSE COCJIN MD
3
MODERATORS: HARPREET PALL MD AND DAVID TROENDLE MD
J EMBRYOLOGY MEETS ENDOSCOPY: THE ROLE OF ENDOSCOPY IN CONGENITAL
GASTROINTESTINAL MALFORMATIONS
Michael Manfredi MD, Children’s Hospital Boston
Learning objectives: u u u
Understand the embryological development of commongastrointestinal malformations
To be able to recognize common clinical presentations for gastrointestinal malformations
Understand the role of endoscopy in the diagnosis and treatment of gastrointestinal malformations
J ORAL ABSTRACT PRESENTATION
J STATE OF THE ART RESEARCH LECTURE —
BUILDING A CAREER IN PEDIATRIC ENDOSCOPY RESEARCH
Petar Mamula MD, Children’s Hospital of Philadelphia
Learning objectives: u u u
Discuss the impact of endoscopy research on every day clinical practice
Discuss pediatric endoscopy research career pathway(s)
Discuss pediatric endoscopy research agenda
J ORAL ABSTRACT PRESENTATION
4
MODERATORS: NORBERTO RODRIGUEZ-BAEZ MD AND NAIM ALKHOURI MD
J
THREE DIMENSIONAL PRINTING OF HUMAN LIVER FOR SURGICAL PLANNING AND BEYOND
Nizar Zein MD, The Cleveland Clinic
Learning objectives: u u
Review current technologies in 3D printing
Discuss potential roles of 3D printing of human liver for surgical planning u Summarize current and future potential of bioprinting of human solid organs
J ORAL ABSTRACT PRESENTATION
J MECHANISMS OF HEPATIC STEATOSIS: DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS
Ariel Feldstein MD, University of California, San Diego
Learning objectives: u u u
Describe clinical importance of hepatic steatosis in children
Discuss novel molecular mechanism of fat accumulation in the liver
Introduce novel diagnostic and therapeutic implications of these pathways
J ORAL ABSTRACT PRESENTATION
17
CONCURRENT SESSION III CONTINUES . . .

5
MODERATORS: KERRY JO LEE MD AND JAMES HEUBI MD
J REGULATORY CONSIDERATIONS IN SELECTING AN ENDPOINT
Preeti Venkataraman MD, Food and Drug Administration
Learning objectives: u u
How to review the natural history of a disease to design the trial and select appropriate endpoints
The importance of choosing endpoints that measure the reduction of disease activity and alleviation of symptoms for patients
J CLINICALLY MEANINGFUL ENDPOINTS IN EoE
Glenn Furuta MD, Children’s Hospital Colorado
Learning objectives: u u
Understand challenges to develop meaningful endpoints
Recognize current endpoints for EoE clinical trials and the rationale for their use
6
MODERATORS: JEREMY ADLER MD, MSC AND AJAY GULATI MD
J DEBATE: HEAL THE MUCOSA OR HEAL THE PATIENT?
Cary Sauer MD, Emory Children’s Center vs.
Shehzad Saeed MD, Cincinnati Children’s Hospital Medical Center u u
Learning objectives: u Define treatment endpoints
Debate pro/con of treatment endpoints
Discuss feasibility of treatment endpoints
J
ORAL ABSTRACT PRESENTATION
J
STATE OF THE ART LECTURE—
STATURAL GROWTH IMPAIRMENT IN PEDIATRIC CROHN’S DISEASE
Neera Gupta MD, MAS, Weill Cornell Medical Center
Learning objectives: u Review what is known about the etiology of statural growth impairment and sex differences in statural growth impairment in pediatric Crohn's disease  u Illustrate the importance of utilizing bone age in interpreting statural growth in pediatric Crohn's disease u Strategize next steps to improve our understanding of the underlying mechanisms of statural growth impairment in pediatric Crohn's disease in order to optimize management
J
ORAL ABSTRACT PRESENTATION
7
J NUTRITIONAL ISSUES IN CHOLESTATIC DISEASE
Binita Kamath MBBChir MRCP MTR, The Hospital for Sick Children u u
Learning objectives: u
Evaluate the nutritional status of a child with liver disease
Understand how to provide optimal protein/energy nutrition to a child with liver disease
Appreciate the impact of nutrition on the outcomes of liver disease
J THE GUT BALANCE REVOLUTION
Gerard Mullin MD, The Johns Hopkins University School of Medicine u u
Learning objectives: u
To discuss the influence of the gut microbiome on energy metabolism
To understand how disruption of the gut microbiome can lead to obesity
To know how prebiotic and probiotic foods and supplements may influence weight by favorably altering the gut microbiome
J IRON DEFICIENCY AND THE DEVELOPING BRAIN
Michael Georgieff MD, University of Minnesota
Learning objectives: u Recognize the common causes of iron deficiency in the newborn, infant and toddler u u
Identify the regions of the brain that are particularly vulnerable to early childhood iron deficiency
Characterize the behaviors that are affected by early life iron deficiency
18 # NASPGHAN15

12:00 PM —2:30 PM
12:00 PM —2:00 PM
12:00 PM —2:00 PM
2:00 PM—3:30 PM
1
MODERATORS: ESTELLA ALONSO MD AND SANDEEP GUPTA MD
J IBD: IF MY PATIENT IS WELL ON COMBINATION THERAPY WHAT SHOULD I DO?
BE HAPPY OR DE-ESCALATE THERAPY?
Andrew Grossman MD, Children’s Hospital of Philadelphia
Learning objectives: u Characterize when de-escalation of medical therapy may and may not be appropriate for pediatric
IBD patients u Discuss maintenance treatment and surveillance when de-escalation is deemed appropriate
J LIVER TRANSPLANT AND IMMUNOSUPPRESSION: LESS OR NONE, SAFE OR SORRY?
Sandy Feng MD, PhD, University of California, San Francisco
Learning objectives: u Develop a strategy to identify subclinical deterioration of allograft histology in stable pediatric liver transplant recipients u Evaluate whether a long-term pediatric liver transplant recipient might be an appropriate candidate for immunosuppression minimization or withdrawal
J SHOULD I TREAT EOSINOPHILIC ESOPHAGITIS AS A CHRONIC DISEASE?
Glenn Furuta MD, Children’s Hospital Colorado
Learning objectives: u u
Understand the rationale to treat EoE chronically
Understand the rationale to only treat EoE acutely
2
MODERATORS: MAISAM ABU-EL-HAIJA MD AND ALVIN JAY FREEMAN MD
J “ISLET” THEM TAKE MY WHOLE PANCREAS!
Jaimie Nathan MD, Cincinnati Children’s Hospital Medical Center
Learning objectives: u u u
Review surgical drainage procedures and resections for chronic pancreatitis
Recognize indications and patient evaluation process for total pancreatectomy and islet autotransplantation (TPIAT)
Understand outcomes following total pancreatectomy and islet autotransplantation (TPIAT)
J
ORAL ABSTRACT PRESENTATION
J STATE OF THE ART LECTURE—
SOLVING A PEDIATRIC DILEMMA: DRUG-INDUCED PANCREATITIS
Sohail Husain MD, Children's Hospital of Pittsburgh of UPMC & The University of Pittsburgh
Learning objectives: u u u
Recognize the problem of drug-induced pancreatitis
Discuss insight into novel mechanisms for drug-induced pancreatitis
Understand how to devise strategies to prevent drug-induced pancreatitis
J ORAL ABSTRACT PRESENTATION
3
MODERATORS: SONIA MICHAIL MD AND DAVID SUSKIN MD
J
RECENT ADVANCES IN FMT
David Suskind MD, Seattle Children’s Hospital
J ORAL ABSTRACT PRESENTATION
19
CONCURRENT SESSION IV CONTINUES . . .

3:30 PM—3:45 PM
3:45 PM—5:15 PM
4
STATE OF THE ART RESEARCH LECTURE—
THE PEDIATRIC GUT MICROBIOME: THE FORGOTTEN ORGAN
Sonia Michail MD, Children’s Hospital Los Angeles
ORAL ABSTRACT PRESENTATION
MODERATORS: AJAY KAUL MD AND RINA SANGHAVI MD
J BRAIN-GUT INTERACTIONS: IMPLICATIONS IN NEUROGASTROENTEROLOGY
Kara Gross Margolis MD, Columbia University
Learning objectives: u To understand the developmental similarities between brain and intestinal development u u
To investigate some of the genetic and environmental factors which impact both brain and gut development
To examine the critical impact of serotonin on neurodevelopment and intestinal function and the implications this may have in autism, intestinal inflammatory disease and motility disorders
5
1
J ORAL ABSTRACT PRESENTATION
J THE OVERLAP BETWEEN INFLAMMATORY BOWEL DISEASE AND FUNCTIONAL
GASTROINTESTINAL DISORDERS: CHALLENGES AND TREATMENT IMPLICATIONS
Miguel Saps MD, Nationwide Children’s Hospital
Learning objectives: u u u
Review data on the overlap between IBD and functional gastrointestinal disorders
Discuss possible mechanisms involved in the overlap
Diagnostic challenges and management (conventional and complementary therapy)
ORAL ABSTRACT PRESENTATION
MODERATOR: JENNIFER VERRILL SCHURMAN PHD, ABPP, BCB
J PSYCHOSOCIAL ASPECTS OF CHRONIC GASTROENTEROLOGICAL ILLNESS
Bonney Reed-Knight PhD, Emory University School of Medicine & Children’s Center for Digestive
Healthcare, Atlanta
Learning objectives: u u u
Describe the bidirectional nature of physical and psychological functioning in pediatric patients with chronic GI disorders
List common areas of psychosocial concern across pediatric GI disorders
Explain the value of incorporating psychosocial assessment and treatment into care for patients with chronic GI disorders
J WHAT HAPPENS BEHIND CLOSED DOORS: INS AND OUTS OF PSYCHOLOGICAL TREATMENTS
Katherine Lamparyk Pys.D, Cleveland Clinic Children’s u u
Learning objectives: u Summarize existing research on the efficacy of psychological interventions in treatment of pediatric
GI conditions
Describe the basic principles of cognitive behavioral treatments
Increase awareness of additional psychological strategies and interventions and how they interrelate
J PSYCHOLOGY AND GASTROENTEROLOGY: KEYS TO EFFECTIVE INTEGRATION
Anthony Alioto PhD, BCB, Nationwide Children’s Hospital u u
Learning objectives:
Explain the role of the psychologist in treating patients with chronic GI disorders
Describe current models of psychologist involvement in GI practices u Further develop strategies for effective interdisciplinary communication in clinical care
MODERATORS: JOSE GARZA MD AND MELANIE GREIFER MD
20 CONCURRENT SESSION V CONTINUES . . .

u u u
NERD: A FOUR LETTER WORD?
Rachel Rosen MD, Boston Children’s Hospital
Learning objectives:
To understand the relationship between GERD, NERD, functional heartburn and hypersensitive esophagus
To understand the efficacy of reflux therapies for NERD
To understand the role of diagnostic testing for NERD
J ORAL ABSTRACT PRESENTATION
J STATE OF THE ART RESEARCH LECTURE—
MANIPULATING GUT BACTERIA TO PREVENT THE ONSET OF CELIAC DISEASE
Alessio Fasano MD, Massachusetts General Hospital for Children
Learning objectives: u u u
To review most recent concepts of celiac disease pathogenesis
To discuss new data on the role of gut microbiota in celiac disease onset
To outline possible preventive strategies based on manipulation of gut microbiota in infants at-risk of celiac disease
J ORAL ABSTRACT PRESENTATION
2
MODERATORS: SHEHZAD SAEED MD AND CHARLES SAMSOM MD
J IMPROVECARENOW: EXPANDING ON A DECADE OF LEARNING
Wallace Crandall MD, Nationwide Children’s Hospital
Learning objectives: u u u
ICN accomplishments to date
Limitations of the current work
Important future directions, including the expansion of these concepts to other diseases
J ORAL ABSTRACT PRESENTATION
J STATE OF THE ART RESEARCH LECTURE—
VERY EARLY ONSET IBD IN CHILDREN:  CAUSES, CURES, & CONNUNDRUMS
Scott Snapper MD, Boston Children’s Hospital
Learning objectives: u u u
Review immunodeficiencies that may present with intestinal inflammation
Understand the phenotype, genetics and prognosis for IBD presenting in very young children
Learn an appropriate immunological evaluation of a child with early IBD
J ORAL ABSTRACT PRESENTATION
3
MODERATORS: SYLVIANE FORGET MD AND STACY KAHN MD
J WHEN IS INFORMED CONSENT REALLY INFORMED?
Jeannie Huang MD, University of California, San Diego
Learning objectives: u u u
Participants will have a better understanding of the ethical principles underlying informed consent
Participants will have a better understanding of the issues and current guidelines regarding in formed assent
Participants will better understand demonstrated deficiencies in informed consent for procedures and review effective strategies to improve the consent process
J ETHICS AND ADVOCACY IN THE MODERN ERA OF PEDIATRIC LIVER TRANSPLANTATION IN
THE UNITED STATES
Evelyn Hsu MD, Seattle Children’s Hospital
Learning objectives: u u u
The participants will have a better understanding of the ethical principles behind prioritizing children in deceased liver allocation
The participants will learn about potential strategies for advocating on behalf of children in the larger deceased liver allocation system
The participants will have a better understanding of the ethical issues that surround altruistic living donor liver donation
21
CONCURRENT SESSION V CONTINUES . . .

5:30 PM—6:30 PM
J THE ETHICS OF INVESTIGATIONAL AND COMPASSIONATE USES
Kevin Donovan MD, Georgetown School of Medicine
Learning objectives: u u u
Will be able to differentiate between approved, unapproved, and extended access to drugs and devices
Identify conflicts and situations that might make unapproved use desirable or necessary
Articulate the ethical conflicts that surround such usages
4
MODERATORS: UDEME EKONG MD AND ALEX MIETHKE MD
J LONG TERM MANAGEMENT OF THE POST PEDIATRIC LIVER TRANSPLANT PATIENT:
SOMETHING FOR EVERYONE TO CARE ABOUT
Vicky Lee Ng MD, The Hospital for Sick Children
Learning objectives: u u u
Provide a 2015 update on survival and health status achievable by pediatric liver transplantation
Understand that long-term management of this patient population involves combined and integrated efforts
Consider key gap opportunities available for focused strategies and new discoveries
J ORAL ABSTRACT PRESENTATION
J STATE OF THE ART RESEARCH LECTURE—UNIQUE ASPECTS OF NEONATAL IMMUNITY
PROVIDE CLUES TO THE PATHOGENESIS OF BILIARY ATRESIA
Cara Mack MD, Children’s Hospital of Colorado
Learning objectives: u u u
Provide current data pertaining to outcomes in biliary atresia
Increase knowledge on adaptive immune mechanisms in neonates
Understand altered adaptive immune responses contributing to bile duct injury in infants with biliary atresia
J ORAL ABSTRACT PRESENTATION
5
MODERATOR: ANTHONY ALIOTO PHD, BCB
J ABDOMINAL PAIN: INTEGRATING PSYCHOLOGICAL TREATMENTS INTO MEDICAL CARE
Miranda vanTilburg PhD, University of North Carolina, Center for Functional GI & Motility Disorders
Learning objectives: u u u
Describe the role of psychosocial factors in functional abdominal pain disorders
Identify evidence-based psychological/behavioral treatments for functional abdominal pain disorders and how to integrate with medical care
Identify patients most likely to benefit from integrated care
J CONSTIPATION AND SOILING: INTEGRATED MODELS OF CARE
Rose Schroedl PhD, Nationwide Children’s Hospital
Learning objectives: u u u
Summarize integrated models of care for constipation and fecal incontinence
Discuss the evidence-base for integrated models of care
Describe an algorithm for treatment decision making
J INTERDISCIPLINARY INPATIENT APPROACHES TO WEANING TUBE DEPENDENT CHILDREN
FROM ENTERAL FEEDING
Alan Silverman PhD, Medical College of Wisconsin
Learning objectives: u Summarize the current state of empirical support for interdisciplinary treatment approaches to weaning tube dependent children from enteral feeding u List methods for medical oversight that can help to ensure the safety of patients undergoing treatment
7:00 PM—11:00 PM
22 # NASPGHAN15

Sunday, October 11, 2015
8:00 AM —11:30 AM
8:00 AM —8:05 AM
8:05 AM —8:30 AM
8:30 AM —8:55 AM
8:55 AM —9:20 AM
9:20 AM —9:45 AM
9:45 AM —9:55 AM
9:55 AM—10:20 AM
10:20 AM—10:45 AM
10:45 AM—11:10AM
11:10AM—11:30AM
WELCOME/INTRODUCTION
HOW TO GET STARTED: YOUR FIRST STUDY
Maria Oliva-Hemker MD, Johns Hopkins University
Learning objectives: u Learn the steps involved in developing a hypothesis u u
Understand the importance of mentorship and  the research team
Recognize factors involved in the regulatory and funding environments u u
PRACTICAL ASPECTS OF LIFE AS A PHYSICIAN-SCIENTIST:
INNOVATION, FUNDING AND SUPPORT
Glenn Furuta MD, Children’s Hospital Colorado
Learning objectives:
Develop an understanding of ways to keep your professional life innovative and productive
Identify ways to maintain funding and support your research u u u
BRANDING: HOW TO ESTABLISH YOUR RESEARCH NICHE
Marla Dubinsky, Mount Sinai Medical Center
Learning objectives:
To indicate ways of discovering a niche
To formulate a mentor-mentee relationship
To integrate passion into research u u u
HOW TO LEVERAGE RESOURCES OF THE CTSA FOR YOUR RESEARCH
James Heubi MD, Cincinnati Children’s Hospital Medical Center
Learning objectives:
Define the resources within the CTSA Hubs to support clinical/translational research
Describe education and career development opportunities with the CTSA Hubs
Define the role of the CTSA consortium in facilitating research processes
BREAK
TEAM SCIENCE: HOW TO DEVELOP AND LEAD A MULTICENTER STUDY AND
HOW TO CLIMB THE LADDER ON THE TEAM
Karen Murray MD, Seattle Children’s Hospital u u
Learning objectives: u
Appreciate the types of multicenter trials and their administration
Recognize the strengths of multicenter research for recruitment and scientific collaboration
DCCs, DMBs, DSMBs, Federal, and Foundation partners- what you need and when
UTILIZING SOCIAL MEDIA TO ADVANCE YOUR RESEARCH AGENDA
Eric Benchimol MD, Children’s Hospital of Eastern Ontario u u
Learning objectives: u
To discuss the advantages of using social media for research dissemination
To review the use of social media for research recruitment and scientific collaboration
To discuss the perils and pitfalls of using social media for professional and scientific purposes u u u
HOW TO BE A WONDERFUL MENTOR AND SPONSOR
Sam Nurko MD, Children’s Hospital Boston
Learning objectives:
Describe the characteristics of a successful mentor
Describe the mutual expectations between mentor and mentee
Pitfalls to avoid when choosing a mentor
QUESTIONS/DISCUSSION
23 # NASPGHAN15

October 9–10, 2015
Friday, October 9, 2015
7:30 AM —8 :1 5 AM
8 :1 5 AM —8:45 AM
8:45 AM—10:00 AM
10:00AM—10:30AM
10:30 AM—12:00PM
REGISTRATION/BREAKFAST/WELCOME
BUSINESS MEETING
KEYNOTE ADDRESS—DEMONSTRATE YOUR POWER IN POLICY: STRENGTH IN NUMBERS
Catherine M. Haut RN, DNP, CPNP, CCRN
BREAK
CONCURRENT SESSIONS (SELECT ONE)
1
MODERATORS: JENNIFER STROPLE MD AND KARA GROSS MARGOLIS MD
J THE EoE HUNGER GAMES: PPI-REE IS CATCHING FIRE!
Edaire Cheng MD, UT Southwestern Medical Center
Learning objectives: u u u
Recognize the similarities, differences, and relationship between GERD, EoE, and PPI-REE
Understand the mechanism of PPI response in PPI-REE patients
Evaluate and treat a patient with esophageal eosinophilia
J USE OF CONCOMITANT IMMUNOMODULATORS AND ANTI-TNFS: EMERGING INSIGHTS
Laurie Conklin MD, Children’s National Medical Center
Learning objectives: u u u u
Discuss the evidence for use of concomitant immunomodulators and anti-TNFs
Discuss the effect of concomitant immunomodulators on immunogenicity
Discuss the effect of concomitant immunomodulators on anti-TNF levels
Examine data regarding outcomes when stopping one class of drug
J
INTRACTABLE CONSTIPATION: WHAT IS NEXT WHEN YOU ARE STUCK?
Jose Garza MD, Children’s Center for Digestive Healthcare, Atlanta
Learning objectives: u Understand colorectal physiology and defecation dynamics u u
Distinguish causes of treatment failure in chronic constipation
Enumerate indications of colorectal manometric studies
2
MODERATORS: ELIZABETH UTTERSON MD AND STEVEN ERDMAN MD
J WHEN THE GOING GETS TOUGH: IMPROVING OUTCOMES OF COLONOSCOPY
Jenifer Lightdale MD, UMass Memorial Children’s Hospital
Learning objectives: u Identify core skills required to perform pediatric colonoscopy safely, effectively and comfortably u u
Review basic and advanced measures which may help in the performance of difficult colonoscopy
Discuss evidence-based estimates of procedural volume required to achieve competence in colonoscopy u Recognize the value of implementing routine continuous assessment of colonoscopy quality to im proving procedural outcomes in an endoscopy unit
24
APGNN ANNUAL MEETING CONTINUES . . .

J ORAL ABSTRACT PRESENTATION
J
POLYPECTOMY: WHO, WHEN, WHY AND HOW
Seth Septer MD, Children’s Mercy Hospital
Learning objectives: u u u
Define the most common causes of polyposis in pediatrics and the risks associated with these polyps
Understand the indications for polypectomy and the recommendations for endoscopic surveillance in patients with polyposis
Review the techniques and equipment used for polypectomy and the potential complications that may occur
J ORAL ABSTRACT PRESENTATION
3
J
PRESENTATION AND DIAGNOSIS
Stefano Guandalini MD, University of Chicago Comer Children's Hospital
J NUTRITION: CELIAC DIET
Pamela A. Cureton RDN, LDN, Massachusetts General Hospital for Children
12:00PM—1:00 PM
1:00 PM—3:00 PM
POSTERS AND LUNCH
INFLAMMATORY BOWEL DISEASE MODULE
J IBD UPDATE
Zarela Molle-Rios MD, Nemours DuPont Pediatrics
J ENTERAL THERAPY
Jen Smith MS, RR, CSP, LD, LMT, Nationwide Children’s Hospital
J IBD & PSYCHOLOGICAL IMPACT
Laura Mackner PhD, Nationwide Children’s Hospital, Brandi N. Whitaker PhD, Arkansas Children’s
Hospital and Cheyenne Hughes-Reed PhD, Nemours/A.I. duPont Hospital for Children
3:00PM—3:15 PM BREAK
3:15 PM—4:15 PM ARE YOU SMARTER THAN A 5TH GRADER?
Norberto Rodriguez-Baez MD, Children’s Medical Center of Dallas
4:15 PM—4:30 PM CONFERENCE WRAP UP
Saturday, October 10, 2015
8:00 AM—8:30 AM
8:30 AM—10:15 AM
10:15 AM—10:30 AM
BREAKFAST AND REGISTRATION
MOTILITY
J COLONIC MOTILITY
Jason Dranove MD, Levine Children's Hospital
J ESOPHAGEAL AND GASTRIC MOTILITY
Jose Cocjin MD, Children's Mercy Hospital
J MOTILITY APN/RN ROLE
Keri Dowds BSN, RN Children’s Hospital of Philadelphia
BREAK
25
APGNN ANNUAL MEETING CONTINUES . . .

10:30 AM—11:45 AM
11:45 AM—12:30 PM
12:30 PM—2:00 PM
2:00 PM—2:45 PM
2:45 PM—3:15 PM
3:15 PM—3:30 PM
3:30 PM—3:45 PM
3:45 PM—5:15 PM
EOSINOPHILIC ESOPHAGITIS
J EoE
Maria Manuel-Rubio RN, BSN,MSN,APN, Children’s Memorial Hospital
J
NUTRITIONAL INTERVENTIONS
Wendy Elverson RD, LDN, Children’s Hospital Boston
CHILDHOOD OBESITY
Nailah Japera Coleman, MD, FAAP, FACSM Children’s National Health System
LUNCH AND POSTERS
RADIOLOGY
Nakul Jerath MD, Inova Children's Hospital
ZEBRAS
CONFERENCE WRAP UP
BREAK
PSYCHOLOGY II—
BIO-BEHAVIORAL ASPECTS OF AND TREATMENTS FOR SPECIFIC GI CONDITIONS
MODERATOR: ANTHONY ALIOTO PHD, BCB
J ABDOMINAL PAIN: INTEGRATING PSYCHOLOGICAL TREATMENTS INTO MEDICAL CARE
Miranda vanTilburg PhD, University of North Carolina, Center for Functional GI and Motility Disorders
Learning objectives: u u
Describe the role of psychosocial factors in functional abdominal pain disorders
Identify evidence-based psychological/behavioral treatments for functional abdominal pain disorders and how to integrate with medical care u Identify patients most likely to benefit from integrated care
J
CONSTIPATION AND SOILING: INTEGRATED MODELS OF CARE
Rose Schroedl PhD, Nationwide Children’s Hospital
Learning objectives: u Summarize integrated models of care for constipation and fecal incontinence u u
Discuss the evidence-base for integrated models of care
Describe an algorithm for treatment decision making
J INTERDISCIPLINARY INPATIENT APPROACHES TO WEANING TUBE DEPENDENT CHILDREN
FROM ENTERAL FEEDING
Alan Silverman PhD, Medical College of Wisconsin
Learning objectives: u u u
Describe existing interdisciplinary care models for weaning tube dependent children
Summarize the current state of empirical support for interdisciplinary treatment approaches to weaning tube dependent children from enteral feeding
List methods for medical oversight that can help to ensure the safety of patients undergoing treatment
26 # NASPGHAN15

CPNP
October 9–10, 2015
Friday, October 9, 2015
7:00 AM —8:00 AM
8:15 AM —10:30 AM
(SEPARATE REGISTRATION REQUIRED)
J EoE AND ELIMINATION DIETS
Amir Kagalwalla MD and Sally Schwartz RD
J BASIC SCIENCE YEAR IN REVIEW
Nicola Jones MD, PhD, The Hospital for Sick Children
J NASPGHAN BUSINESS MEETING
J CLINICAL SCIENCE YEAR IN REVIEW
William Balistreri MD, Cincinnati Children’s Hospital Medical Center
10:30 AM—12:00 PM
1
MODERATORS: RUSSELL MERRITT MD AND ALA SHAIKHKHALIL MD
J LONG TERM COMPLICATIONS OF TPN: NOW THAT MY INTESTINAL FAILURE PATIENTS ARE
NOT DYING OF LIVER DISEASE, WHAT ELSE SHOULD I WORRY ABOUT?
Jane Balint MD, Nationwide Children’s Hospital
Learning objectives: u
Identify potential complications of lipid minimization strategies  u Describe an approach to micronutrient monitoring in long term parenteral nutrition u Discuss renal and bone complications of parenteral nutrition
J ORAL ABSTRACT PRESENTATION
J COMBATING CLABSIS—
PREVENTING CENTRAL LINE INFECTIONS AND OTHER CENTRAL LINE CHALLENGES
John Kerner MD, Lucile Packard Children’s Hospital
Learning objectives: u Identify evidence based practices for CLABSI prevention u u
Describe at least one modality for the prevention of catheter-related venous thrombosis
Discuss the approach to the patient with central line occlusion
J ORAL ABSTRACT PRESENTATION
2
MODERATORS: MICHELLE PIETZAK MD AND MARIA MASCARENHAS MBBS
J ADVANCES IN CF THERAPIES AND THEIR EFFECT ON GASTROINTESTINAL MANIFESTATIONS
Daniel Gelfond MD, WNY Pediatric Gastroenterology
Learning objectives: u u u u
Outline pathophysiology of CF and impact of CFTR on clinical manifestations
Recognize gastrointestinal manifestations of the Cystic fibrosis and discuss therapeutic interventions
Outline recent development and advances in CF therapy targeting specific genetic mutations
Discuss role of wireless motility capsule as gastrointestinal biomarker of CFTR activity
J ORAL ABSTRACT PRESENTATION
27
CPNP SYMPOSIUM CONTINUES . . .

J DISCORDANT SEROLOGIES AND BIOPSIES: WHAT TO DO?
Dascha C. Weir MD, Boston Children's Hospital
Learning objectives: u Recognize the potential complexities in the use of celiac serologic markers and small intestinal biopsies in clinical practice u Discuss a clinical approach to the treatment and monitoring of patients with discordant serology and biopsies
J
ORAL ABSTRACT PRESENTATION
2:30 PM—4:00 PM
5:00 PM—7:00 PM
1 u u
MODERATORS: STEPHANIE ABRAMS, AMAL AQUL, SARAH BARLOW, MOLLY BOZIC, NIRAV
DESAI, RIMA FAWAZ, ARIEL FELDSTEIN, REGY GONZALES-PERALTA, NITIKA GUPTA, SIMON
HORSLEN, EVELYN HSU, ROHIT KOHLI, JEAN MOLLESTON, NADIA OVCHINSKY, EMILY PERITO,
JEFF SCHWIMMER, DELLYS SOLER-RODRIGUEZ AND SHIKHA SUNDARAM
Miriam Vos MD, MSPH, FAHA—Emory School of Medicine
Learning objectives: u To address when to biopsy and when to re-biopsy in pediatric NAFLD
To understand dyslipidemia in the setting of NAFLD– how to assess and when to start medications
To discuss treatment with Vitamin E (and other medications)
2
MODERATORS: RUBA ABDELHADI MD AND TIMOTHY SENTONGO MD
J BACTERIAL OVERGROWTH IN PEDIATRIC SHORT BOWEL SYNDROME
Conrad Cole MD, Cincinnati Children’s Hospital Medical Center
Learning objectives: u u u u
Learn risk factors for developing bacterial overgrowth
Discuss diagnostic challenges
Understand the differential diagnosis
Review therapeutic options
J ORAL ABSTRACT PRESENTATION
J
STATE OF THE ART RESEARCH LECTURE—CUTTING EDGE OR CRAZY: IS SURGERY THE
MOST EFFECTIVE TREATMENT FOR NASH?
Stavra Xanthakos MD u u
Learning objectives:
Review the current guidelines for when to consider bariatric surgery in youth u
Describe the types of bariatric surgeries performed in adolescents, including risks and benefits
Review the evidence and gaps in knowledge re: bariatric surgery as a specific treatment for NASH
J ORAL ABSTRACT PRESENTATION
28 # NASPGHAN15

Saturday, October 10, 2015
7:30 AM —8:00 AM
8:00 AM —8:05 AM
8:05 AM —8:45 AM
8:45 AM —9:1 5 AM
9:1 5 AM — 9:45 AM
9:45 AM —10:15 AM
Praveen Goday MBBS, CNSC, Chair, NAPGHAN Nutrition Committee
Shikha Sundaram MD, MSCIMD and Helen Seagle MS, RDNRD, Children’s Hospital Colorado
Lori Bechard PhD, Med, RD, LDN, Boston Children’s Hospital
Cade Nylund MD, MS, FAAP, Walter Reed National Military Medical Center
Tami Miller RD, CSP, CDRD, Children’s Hospital of Wisconsin
10:15 AM—10:30 AM
10:30 AM—11:00 AM
11:00 AM—11:30 AM
11:30 AM—12:00 PM
12:00 PM—1:00 PM
1:00 PM— 1 : 3 5 PM
1:40 PM— 3:10 PM
3:10 PM— 4:15 PM
Binita Kamath MBBChir, MRCP, MTR, The Hospital for Sick Children
Gerard Mullin, MD, The Johns Hopkins University School of Medicine
Michael Georgieff, MD, University of Minnesota
Athos Bousvaros MD, MPH and Karen Warman MS, RD, Boston Children’s Hospital
J
THE ELIMINATION DIET: PRACTICAL TIPS AND PITFALLS
Wendy Elverson RD, LDN, Boston Children’s Hospital
J
ASSESSING NUTRITIONAL NEEDS IN THE HYPOMETABOLIC CHILD
Monica Cicchini, MS, RD, CSP, LD, Georgetown University Hospital
J
NUTRITION CARE FOR CHILDREN UNDERGOING HEMATOPOIETIC CELL TRANSPLANTATION,
NOW AND LATER
Lori Bechard PhD, Med, RD, LDN, Boston Children’s Hospital
J TROUBLESHOOTING PANCREATIC ENZYME THERAPY (PERT) IN CYSTIC FIBROSIS
Tami Miller RD, CSP, CDRD, Children’s Hospital of Wisconsin
J NUTRITIONAL ISSUES IN ALAGILLE SYNDROME
Binita Kamath MBBChir, MRCP, MTR, The Hospital for Sick Children
J INFLAMMATORY BOWEL DISEASE
Karen Warman MS, RD, Boston Children’s Hospital
Margaret Girten RD, CSP, LDN and Julia Driggers RD, LDN, CNSC, Children’s Hospital of Philadelphia
29
CPNP SYMPOSIUM CONTINUES . . .

3:45 PM—5:15 PM
J MODERATOR: ANTHONY ALIOTO, PHD, BCB
ABDOMINAL PAIN: INTEGRATING PSYCHOLOGICAL TREATMENTS INTO MEDICAL CARE
Miranda vanTilburg PhD, University of North Carolina, Center for Functional GI and Motility Disorders
Learning objectives: u u
Describe the role of psychosocial factors in functional abdominal pain disorders
Identify evidence-based psychological/behavioral treatments for functional abdominal pain disorders and how to integrate with medical care u Identify patients most likely to benefit from integrated care
J CONSTIPATION AND SOILING: INTEGRATED MODELS OF CARE
Rose Schroedl PhD, Nationwide Children’s Hospital
Learning objectives: u Summarize integrated models of care for constipation and fecal incontinence u u
Discuss the evidence-base for integrated models of care
Describe an algorithm for treatment decision making
J INTERDISCIPLINARY INPATIENT APPROACHES TO WEANING TUBE DEPENDENT CHILDREN
FROM ENTERAL FEEDING
Alan Silverman PhD, Medical College of Wisconsin
Learning objectives: u u
Describe existing interdisciplinary care models for weaning tube dependent children
Summarize the current state of empirical support for interdisciplinary treatment approaches to weaning tube dependent children from enteral feeding u List methods for medical oversight that can help to ensure the safety of patients undergoing treatment
30 # NASPGHAN15

Teaching & Tomorrow 2015
We are pleased to announce the 2015 Pediatric GI Teaching and Tomorrow Program of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). Our goal is to attract the best and brightest residents to subspecialty training in pediatric gastroenterology, hepatology and nutrition. In order to accomplish this goal, we have created the Teaching and Tomorrow Program. This program brings pediatric residents from North America to our Annual NASPGHAN Meeting to see first-hand the cutting edge basic and clinical science of our subspecialty.
This year, the conference will take place October 8-11, 2015. During this period we will also meet with these residents, to share our enthusiasm for pediatric gastroenterology hepatology and nutrition and to offer career guidance.
WHAT:
WHERE:
ARRIVE:
DEPART:
Attend NASPGHAN Annual Meeting and Postgraduate Course
Washington, DC
October 7, 2015 (Evening)
October 11, 2015
ELIGIBILITY: Pediatric Residents with an interest in pediatric gastroenterology, hepatology and nutrition. It is expected that those selected will be the equivalent of a PL-2 resident at the time of the meeting or PL-3 residents considering applying for fellowship to begin in July 2017.
SUPPORT: NASPGHAN will provide support by extending a reduced registration fee of $200 that includes registration for the Postgraduate Course, Annual Meeting and all the Teaching and Tomorrow events. This includes orientation breakfast on Thursday, a luncheon program on Thursday, the reception on Friday and the closing breakfast on Saturday morning. Participants or sponsoring institutions will be responsible for all travel and hotel costs associated with the meeting.
NASPGHAN will assist attendees in making double hotel accommodations for those who are interested.
Please email your gender, and arrival and departure dates to bzaitz@naspghan.org. We will need your hotel information no later than August 3, in order to reserve a room for you. After August 3, we will not be able to assist you with room reservations.
APPLICATION:
Residents should register for the meeting by using the attached registration form or by registering on-line.
Teaching and Tomorrow participants will be emailed a pre-test prior to the meeting.
DEADLINE: September 2, 2015
31 # NASPGHAN15

Registration Form
u Early-Bird Registration Deadline: August 3, 2015
(To receive Early-Bird rates, envelopes must be postmarked no later than August 3 rd , or standard rates will apply) u After August 3 rd , Standard Rates apply and fees for Postgraduate Course and Annual Meeting increase by $50 each per category.
u After September 2 nd , rates increase again to on-site rates and fees for Postgraduate Course and Annual Meeting rise an additional
$50 each per category.
u Register online at (www.naspghan.org)
Fill in below information with a complete address indicating where registration/meeting material should be mailed. Please print clearly.
First Name
Address
City
Phone
Email (Required)
Last Name
State
Fax
Zip Country
(For Details See Page 4)
Check your member type Early Bird Rates Standard Rates
Deadline 8/3/15** Deadline 9/2/15
Member
Non-Member
Trainee/Fellow Member
Non-Member Trainee
Psychologist
Student/Resident
$200
$250
$150
$200
$150
$100
$200
$250
$150
$200
$150
$100
After 9/2/15
Allied Health Professional $150 $150
**To receive Early-Bird rates, envelopes must be postmarked no later than August 3, 2015
$250
$300
$200
$250
$200
$150
$200
Amount Owed
(For Details See Page 5)
NASPGHAN Advocacy Program: $50 (See Page 5 ) Amount Owed
Check Box if Attending
32 # NASPGHAN15

(For Details See Pages 6—9)
Check your member type
Early Bird Rates
Deadline 8/3/15**
Standard Rates
Deadline 9/2/15
After 9/2/15
Member
Non-Member
Trainee/Fellow Member
Non-Member Trainee
Psychologist
Student/Resident
$325
$425
$200
$250
$200
$125
$375
$475
$250
$300
$250
$175
Allied Health Professional $250 $300
**To receive Early-Bird rates, envelopes must be postmarked no later than August 3, 2015
$425
$525
$300
$350
$300
$225
$350
Amount Owed
(For Learning Lunch Selections See Page 8)
Learning Lunches: $25 (See Page 8 for Lunch Choices and indicate choice by # below) Amount Owed
First Choice: #_______ Second Choice: #_______ Third Choice: #_______
(For Details See Pages 10—23)
Check your member type
Early Bird Rates
Deadline 8/3/15**
Standard Rates
Deadline 9/2/15
After 9/2/15 Amount Owed
Member
Non-Member
Trainee/Fellow Member
Non-Member Trainee
Psychologist
Student/Resident
$325
$500
$200
$275
$125
$75
$375
$550
$250
$325
$175
$125
Allied Health Professional $225 $275
**To receive Early-Bird rates, envelopes must be postmarked no later than August 3, 2015
$425
$600
$300
$375
$225
$175
$325
Indicate All Choices Fee Amount Owed
Virtual NAFLD (Friday 2:30pm—4pm) See Page 12
Professional Dev. Workshop (Friday 6pm—8pm) See Page 14
Hands On Motility (Saturday 10:30 am—12:00) See Page 17
50 total slots; first come first served
Meet the Professor Breakfast (Friday, 10/9) See Page 10
Meet the P rofessor Breakfast (Saturday, 10/10) See Page 16
Saturday Social Event
No charge
No charge
No charge
$40 Indicate choices in box below
$40 Indicate choices in box below
No charge/Indicate if attending Yes______ No______
Extra Ticket(s) for Saturday Social Event (Adult)
Extra Ticket(s) for Saturday Social Event (Child)
Sunday Research Skills Workshop
$75
$25
No charge/Indicate if attending
TOTAL
Yes______ No______
$
(For Friday Sessions See Pages 10) (For Saturday Sessions See Pages 16)
Friday, October 9, 2015 (indicate choice by # below)
1st Choice: #______
2nd Choice: #______
Saturday, October 10, 2015 (indicate choice by # below)
1st Choice: #______
2nd Choice: #______
3rd Choice: #______
3rd Choice: #______
33 Please fill out payment information on the following page

Payment Information: MasterCard Visa Discover American Express
Credit Card #: ______________________________________________________________________________________Verification Code#:_________________ Expiration: ______________________
Make checks (drawn on a US bank in US funds) payable to “NASPGHAN”
Mail or Fax completed form to — Mail: NASPGHAN / PO Box 6 / Flourtown, PA 19031 — Fax: 215-233-3918
Contact NASPGHAN National Office if further information is needed
Phone: 215-233-0808
Fax: 215-233-3918
Email: naspghan@naspghan.org
Web: www.naspghan.org
NASPGHAN Federal Tax ID: 84-126-4996
NASPGHAN POSTGRADUATE COURSE—
Registration fees include Postgraduate course syllabus, continental breakfast, and coffee breaks.
NASPGHAN ANNUAL MEETING—
Registration fees for the Annual Meeting include the wine and cheese reception on Thursday evening, continental breakfast on Friday and Saturday morning, coffee breaks, social event on Saturday evening, and continental breakfast at Research Skills Workshop Sunday morning.
Written cancellations and refund requests must be received on or before September 16, 2015. Requests will not be honored after this date. A registration receipt must accompany requests. A refund of the registration fee, minus a $50 administrative fee per each registered item, will be issued after the meeting.
Please indicate you understand this policy with a signature: _____________________________________________________ __________________________________________________________________
NASPGHAN Annual Meeting Registration
PO Box 6
Flourtown, PA 19031
34 # NASPGHAN15

Registration Form
u Early-Bird Registration Deadline: August 3, 2015
(To receive Early-Bird rates, envelopes must be postmarked no later than August 3 rd , or standard rates will apply) u After August 3 rd , Standard Rates apply and fees for Postgraduate Course and Annual Meeting increase by $50 each per category.
u After September 2 nd , rates increase again to on-site rates and fees for Postgraduate Course and Annual Meeting rise an additional
$50 each per category.
u Register online at (www.naspghan.org)
Fill in below information with a complete address indicating where registration/meeting material should be mailed. Please print clearly.
Last Name First Name
Address
City
Phone
Zip Country State
Fax
Email (Required)
(For Details See Page 4)
Check your member type
Early Bird Rates
Deadline 8/3/15**
$150
Standard Rates
Deadline 9/2/15
$150
After 9/2/15
APGNN Member
Non-Member Nurse $200 $200
Allied Health Professional $150 $150
**To receive Early-Bird rates, envelopes must be postmarked no later than August 3, 2015
$200
$250
$200
Amount Owed
(For Details See Page 5)
NASPGHAN Advocacy Program: $50 (See Page 7 ) Amount Owed
Check Box if Attending
(For Details See Pages 6—9)
Check your member type
Early Bird Rates
Deadline 8/3/15**
Standard Rates
Deadline 9/2/15
After 9/2/15 Amount Owed
APGNN Member
Non-Member Nurse
$200
$250
$250
$300
Allied Health Professional $250 $300
**To receive Early-Bird rates, envelopes must be postmarked no later than August 3, 2015
$300
$350
$350
35 # NASPGHAN15

(For Learning Lunch Selections See Page 8)
Learning Lunches: $25 (See Page 8 for Lunch Choices and indicate choice by # below)
First Choice: #_______ Second Choice: #_______ Third Choice: #_______
Amount Owed
(For Details See Pages 24—26)
(YOU CAN ATTEND SESSIONS IN BOTH MEETINGS.)
Check your member type
Early Bird Rates
Deadline 8/3/15**
Standard Rates
Deadline 9/2/15
$225
After 9/2/15
APGNN Member $175
Non-Member Nurse $225 $275
Allied Health Professional $225 $275
**To receive Early-Bird rates, envelopes must be postmarked no later than August 3, 2015
$275
$325
$325
Amount Owed
Indicate All Choices
Virtual NAFLD (Friday 2:30pm—4pm) See Page 12
Professional Dev. Workshop (Friday 6pm—8pm) See Page 14
Hands On Motility (Saturday 10:30 am—12:00) See Page 17
50 total slots; first come first served
Meet the Professor Breakfast (Friday, 10/9) See Page 10
Meet the P rofessor Breakfast (Saturday, 10/10) See Page 16
Friday APGNN Social Event
Extra Ticket(s) for Saturday Social Event (Adult)
Extra Ticket(s) for Saturday Social Event (Child)
Sunday Research Skills Workshop
Fee
No charge
No charge
No charge
$40 Indicate choices in box below
$40 Indicate choices in box below
No charge/Indicate if attending
$75
$25
No charge/Indicate if attending
TOTAL
Amount Owed
Yes______ No______
$
Yes No
(For Friday Sessions See Pages 10) (For Saturday Sessions See Pages 16)
Friday, October 9, 2015 (indicate choice by # below)
1st Choice: #______
2nd Choice: #______
3rd Choice: #______
Saturday, October 10, 2015 (indicate choice by # below)
1st Choice: #______
2nd Choice: #______
3rd Choice: #______
36 # NASPGHAN15

Payment Information: MasterCard Visa Discover American Express
Credit Card #: ______________________________________________________________________________________Verification Code#:_________________ Expiration: ______________________
Make checks (drawn on a US bank in US funds) payable to “NASPGHAN”
Mail or Fax completed form to — Mail: NASPGHAN / PO Box 6 / Flourtown, PA 19031 — Fax: 215-233-3918
Contact NASPGHAN National Office if further information is needed
Phone: 215-233-0808
Fax: 215-233-3918
Email: naspghan@naspghan.org
Web: www.naspghan.org
NASPGHAN Federal Tax ID: 84-126-4996
NASPGHAN POSTGRADUATE COURSE—
Registration fees include Postgraduate course syllabus, continental breakfast, and coffee breaks.
APGNN-NASPGHAN ANNUAL MEETING—
Registration fees for the Annual Meeting include the wine and cheese reception on Thursday evening, continental breakfast on Friday and Saturday mornings, coffee breaks, APGNN social event Friday evening and the social event on Saturday evening.
Nurses and Allied Health Professionals may attend APGNN or NASPGHAN sessions. Nursing continuing education (contact hours) credits will only be available for the APGNN sessions. Continuing medical education (CME) credit hours can be obtained through
NASPGHAN for the NASPGHAN sessions. If you have any questions regarding the nursing contact hours, please contact Maureen
Egan at (maegan@nemours.org).
Written cancellations and refund requests must be received on or before September 16, 2015. Requests will not be honored after this date. A registration receipt must accompany requests. A refund of the registration fee, minus a $50 administrative fee per each registered item, will be issued after the meeting.
Please indicate you understand this policy with a signature: _____________________________________________________ __________________________________________________________________
NASPGHAN Annual Meeting Registration
PO Box 6
Flourtown, PA 19031
37 # NASPGHAN15

Registration Form
u Early-Bird Registration Deadline: August 3, 2015
(To receive Early-Bird rates, envelopes must be postmarked no later than August 3 rd , or standard rates will apply) u After August 3 rd , Standard Rates apply and fees for Postgraduate Course and Annual Meeting increase by $50 each per category.
u After September 2 nd , rates increase again to on-site rates and fees for Postgraduate Course and Annual Meeting rise an additional
$50 each per category.
u Register online at (www.naspghan.org)
Fill in below information with a complete address indicating where registration/meeting material should be mailed. Please print clearly.
First Name
Address
City
Phone
Email (Required)
Last Name
State
Fax
Zip Country
(For Details See Page 4)
Check your member type
Early Bird Rates
Deadline 8/3/15**
Standard Rates
Deadline 9/2/15
CPNP Member $150 $150
Non-Member Nutritional Professional $200 $200
Allied Health Professional $150 $150
**To receive Early-Bird rates, envelopes must be postmarked no later than August 3, 2015
After 9/2/15
$200
$250
$200
Amount Owed
(For Details See Page 5)
NASPGHAN Advocacy Program: $50 (See Page 7 ) Amount Owed
Check Box if Attending
(For Details See Pages 6—9)
Check your member type
Early Bird Rates
Deadline 8/3/15**
Standard Rates
Deadline 9/2/15
After 9/2/15
CPNP Member $200 $250
Non-Member Nutritional Professional
Allied Health Professional
$250
$250
$300
$300
**To receive Early-Bird rates, envelopes must be postmarked no later than August 3, 2015
$300
$350
$350
Amount Owed
38 # NASPGHAN15

(For Learning Lunch Selections See Page 8)
Learning Lunches: $25 (See Page 8 for Lunch Choices and indicate choice by # below)
First Choice: #_______ Second Choice: #_______ Third Choice: #_______
Amount Owed
(For Details See Pages 27—30)
(YOU CAN ATTEND SESSIONS IN BOTH MEETINGS.)
Check your member type
Early Bird Rates
Deadline 8/3/15**
Standard Rates
Deadline 9/2/15
$200
After 9/2/15
CPNP Member $150
Non-Member Nutritional Professional $200 $250
Allied Health Professional $200 $250
**To receive Early-Bird rates, envelopes must be postmarked no later than August 3, 2015
$200
$250
$250
Amount Owed
Indicate All Choices
Meet the Professor Breakfast (Friday, 10/9) See Page 27
Friday Welcome Reception
Saturday Social Event
Extra Ticket(s) for Saturday Social Event (Adult)
Extra Ticket(s) for Saturday Social Event (Child)
Sunday Research Skills Workshop
Fee
$40
No charge/Indicate if attending
No charge/Indicate if attending
$75
$25
No charge/Indicate if attending
TOTAL
Amount Owed
Yes______ No______
Yes______ No______
$
Yes______ No______
Payment Information: MasterCard Visa Discover American Express
Credit Card #: ______________________________________________________________________________________Verification Code#:_________________ Expiration: ______________________
Make checks (drawn on a US bank in US funds) payable to “NASPGHAN”
Mail or Fax completed form to — Mail: NASPGHAN / PO Box 6 / Flourtown, PA 19031 — Fax: 215-233-3918
Contact NASPGHAN National Office if further information is needed
Phone: 215-233-0808 / Fax: 215-233-3918 / naspghan@naspghan.org / www.naspghan.org / NASPGHAN Federal Tax ID: 84-126-4996
NUTRITION SYMPOSIUM—Registration fees for the Nutrition Symposium include a wine and cheese reception on Friday evening, continental breakfast on Saturday morning, lunch on Saturday, coffee break, and a social event on Saturday evening.
CPNP Members and Nutrition Professionals attending the Nutrition Symposium may also attend APGNN or NASPGHAN sessions.
Nursing continuing education (contact hours) credits can be obtained through APGNN for the APGNN sessions. Continuing medical education (CME) credit hours can be obtained through NASPGHAN for the NASPGHAN sessions. CPUs will be available for the
Nutrition Symposium.
Written cancellations and refund requests must be received on or before September 16, 2015. Requests will not be honored after this date. A registration receipt must accompany requests. A refund of the registration fee, minus a $50 administrative fee per each registered item, will be issued after the meeting.
Please indicate you understand this policy with a signature: _____________________________________________________ __________________________________________________________________
NASPGHAN Annual Meeting Registration / PO Box 6 / Flourtown, PA 19031
39 # NASPGHAN15

Registration Form
Fee: $200.00
Please print clearly
First Name
Address
City
Phone
Last Name
State
Fax
Zip Country
Email
Payment Information: MasterCard Visa Discover American Express Check
Credit Card #: ________________________________________________________________________________________ Expiration Date: ____________________ Security Code: ____________________
Signature of cardholder: ______________________________________________________________________________________________________________________________________________________________________
Please make checks (drawn on a US bank in US funds) payable to “NASPGHAN”
Mail or Fax completed form to — Mail: NASPGHAN / PO Box 6 / Flourtown, PA 19031 — Fax: 215-233-3918
Contact NASPGHAN National Office if further information is needed
Phone: 215-233-0808 — Fax: 215-233-3918 — naspghan@naspghan.org — www.naspghan.org
NASPGHAN Federal Tax ID: 84-126-4996
ELIGIBILITY: It is expected that those selected will be the equivalent of a PL-2 resident at the time of the meeting or PL-3 residents considering applying for fellowship to begin in July 2017.
SUPPORT: Registration includes the Postgraduate Course, Annual Meeting and all the Teaching and Tomorrow events. This includes orientation breakfast on Thursday, a luncheon program on Thursday, the reception on Friday evening and the closing breakfast on Saturday morning.
Participants or sponsoring institutions will be responsible for all travel and hotel costs associated with the meeting.
DEADLINE: September 2, 2015
40 # NASPGHAN15

Registration Form
Entry Fee: $50.00.
Please print clearly
First Name
Address
City
Phone
Email
Last Name
State
Fax
Zip Country
Emergency Contact: Phone:
T-Shirt Size (please circle one): XS SM MD LG XL XXL
Liability Waiver: Upon acceptance of my entry, I, for myself my heirs and assigns, hereby release the City of Washington, DC; Race DC Timing, LLC; NASPGHAN and the NASPGHAN Foundation, all sponsors, and other entities involved with the production of this event from any and all liability arising from illness, injury or death I may suffer as a result of my participation in this event. I attest that I am physically fit and have trained for this event and am aware that my participation could, in some circumstances, result in injury. Should officials determine that completion of this event would be injurious to my health, I consent to be removed and treated by the medical personnel in attendance or their direction. I give permission for free use of my name and picture in any broadcast, telecast or written account of this event. Race will be held rain or shine. NO REFUNDS.
Signature: _________________________________________________________________________________________________________________________________________________________________ Date: __________________________________________
Payment Information:
If you would prefer to not run and just make a donation, please check here Donation Amount: ___________________________________________________________________________
MasterCard Visa Discover American Express Check
Credit Card #: ______________________________________________________________________________________________________________ Expiration Date: ________________________ Security Code: ____________________
Signature of cardholder: _______________________________________________________________________________________________________________________________________________________________________________________________
Please make checks (drawn on a US bank in US funds) payable to “NASPGHAN”
Mail or Fax completed form to Mail: NASPGHAN / PO Box 6 / Flourtown, PA 19031 — Fax: 215-233-3918
Contact NASPGHAN National Office if further information is needed
Phone: 215-233-0808 — Fax: 215-233-3918 — naspghan@naspghan.org — www.naspghan.org
NASPGHAN Federal Tax ID: 84-126-4996
41 # NASPGHAN15